RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $125,150,523.18

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$199.09

▲ +4.863 (2.50%)

As of 11/4/2026 01:24 PM ET

Days: 30 | 90 | 365

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/29/2026	Alan B. Sandler	Insider	Sell	6,309	$202.14	$1,275,301.26	52,559
9/22/2026	Elizabeth M. Anderson	Director	Sell	10,143	$193.04	$1,958,004.72	4,333
9/16/2026	Alan B. Sandler	Insider	Sell	341	$199.24	$67,940.84	52,868
9/16/2026	Jack Anders	CFO	Sell	4,053	$199.24	$807,519.72	119,216
9/16/2026	Margaret A. Horn	COO	Sell	4,967	$199.24	$989,625.08	149,680
9/16/2026	Mark A. Goldsmith	Insider	Sell	13,988	$199.24	$2,786,969.12	253,342
9/16/2026	Stephen Michael Kelsey	Insider	Sell	5,569	$199.24	$1,109,567.56	286,307
9/11/2026	Stephen Michael Kelsey	Insider	Sell	92,531	$202.36	$18,724,573.16	291,876
9/8/2026	Lorence H. Kim	Director	Sell	17,090	$209.82	$3,585,823.80
8/31/2026	Lorence H. Kim	Director	Sell	56,000	$203.24	$11,381,440.00	17,090
8/21/2026	Mark A. Goldsmith	Insider	Sell	80,000	$209.20	$16,736,000.00	267,330
6/29/2026	Sushil Patel	Director	Sell	5,580	$187.99	$1,048,984.20	21,656
6/24/2026	Jack Anders	CFO	Sell	20,000	$168.33	$3,366,600.00	123,269
6/17/2026	Margaret A. Horn	COO	Sell	29,600	$160.12	$4,739,552.00	154,647
6/16/2026	Jack Anders	CFO	Sell	2,722	$156.12	$424,958.64	123,269
6/16/2026	Mark A. Goldsmith	Insider	Sell	10,020	$156.12	$1,564,322.40	267,330
6/16/2026	Stephen Michael Kelsey	Insider	Sell	4,175	$156.12	$651,801.00	291,876
6/15/2026	Margaret A. Horn	COO	Sell	60,400	$160.17	$9,674,268.00	158,222
4/15/2026	Mark A. Goldsmith	Insider	Sell	120,000	$150.09	$18,010,800.00	276,698
3/17/2026	Jack Anders	CFO	Sell	2,753	$99.48	$273,868.44	125,512
3/17/2026	Lin Wei	Insider	Sell	2,073	$99.48	$206,222.04	101,366
3/17/2026	Margaret A. Horn	COO	Sell	4,583	$99.48	$455,916.84	157,570
3/17/2026	Mark A. Goldsmith	Insider	Sell	12,871	$99.48	$1,280,407.08	276,698
3/17/2026	Stephen Michael Kelsey	Insider	Sell	4,302	$99.48	$427,962.96	295,398
3/17/2026	Xiaolin Wang	Insider	Sell	2,010	$99.48	$199,954.80	116,063
3/2/2026	Mark A. Goldsmith	Insider	Sell	30,000	$101.22	$3,036,600.00	289,569
3/2/2026	Mark A. Goldsmith	Insider	Sell	6,000	$101.30	$607,800.00	64,424
1/7/2026	Jack Anders	CFO	Sell	10,000	$98.00	$980,000.00	108,065
1/7/2026	Margaret A. Horn	COO	Sell	75,000	$100.56	$7,542,000.00	141,053
12/16/2025	Jack Anders	CFO	Sell	3,104	$77.09	$239,287.36	108,065
12/16/2025	Margaret A. Horn	COO	Sell	4,847	$76.82	$372,346.54	141,053
12/16/2025	Mark A. Goldsmith	Insider	Sell	15,394	$76.82	$1,182,567.08	232,469
12/16/2025	Stephen Michael Kelsey	Insider	Sell	5,447	$76.82	$418,438.54	278,600
11/25/2025	Mark A. Goldsmith	Insider	Sell	60,000	$75.08	$4,504,800.00	247,863
11/18/2025	Mark A. Goldsmith	Insider	Sell	20,000	$70.38	$1,407,600.00	247,863
11/12/2025	Mark A. Goldsmith	Insider	Sell	20,000	$65.07	$1,301,400.00	247,863
11/7/2025	Mark A. Goldsmith	Insider	Sell	30,000	$60.31	$1,809,300.00	347,863
10/13/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$48.54	$1,213,500.00	284,047
9/16/2025	Jack Anders	CFO	Sell	2,320	$45.82	$106,302.40	110,994
9/16/2025	Lin Wei	Insider	Sell	2,160	$45.82	$98,971.20	88,339
9/16/2025	Margaret A. Horn	COO	Sell	4,775	$45.82	$218,790.50	145,900
9/16/2025	Mark A. Goldsmith	Insider	Sell	13,411	$45.82	$614,492.02	452,309
9/16/2025	Stephen Michael Kelsey	Insider	Sell	5,367	$45.82	$245,915.94	284,047
9/15/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$45.97	$1,149,250.00	289,414
9/11/2025	Stephen Michael Kelsey	Insider	Sell	100,000	$44.08	$4,408,000.00	289,414
9/3/2025	Jack Anders	CFO	Sell	5,238	$40.17	$210,410.46	113,314
9/2/2025	Jack Anders	CFO	Sell	4,762	$40.02	$190,575.24	113,314
6/16/2025	Margaret A. Horn	COO	Sell	3,575	$156.12	$558,129.00	154,647
3/17/2025	Jack Anders	CFO	Sell	1,864	$39.04	$72,770.56	115,006
3/17/2025	Margaret A. Horn	COO	Sell	3,058	$39.04	$119,384.32	153,533
3/17/2025	Mark A. Goldsmith	Insider	Sell	11,738	$39.04	$458,251.52	441,564
12/16/2024	Jack Anders	CFO	Sell	2,635	$45.40	$119,629.00	96,470
12/16/2024	Margaret A. Horn	COO	Sell	4,329	$45.40	$196,536.60	127,991
12/16/2024	Mark A. Goldsmith	Insider	Sell	11,714	$45.40	$531,815.60	325,056
12/5/2024	Thilo Schroeder	Director	Buy	1,304,347	$46.00	$59,999,962.00	2,096,612
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/4/2026	Brighton Jones LLC	3,565	$0.73M	0.0%	+2.9%	0.002%
11/4/2026	Candriam S.C.A.	445,693	$91.82M	0.4%	-19.9%	0.208%
11/3/2026	Ethic Inc.	3,571	$0.73M	0.0%	+32.8%	0.002%
11/3/2026	Pictet Asset Management Holding SA	996,974	$204.53M	0.2%	-1.8%	0.465%
11/3/2026	Parallel Advisors LLC	1,766	$0.36M	0.0%	+30.5%	0.001%
11/3/2026	Alps Advisors Inc.	2,124	$0.44M	0.0%	-3.6%	0.001%
11/3/2026	CenterBook Partners LP	7,460	$1.53M	0.1%	N/A	0.003%
11/3/2026	Heritage Family Offices LLP	777	$0.16M	0.1%	N/A	0.000%
11/2/2026	Alta Advisers Ltd	1,489	$0.31M	0.0%	N/A	0.001%
11/2/2026	Kestra Advisory Services LLC	4,306	$0.88M	0.0%	+236.7%	0.002%
11/2/2026	Commonwealth Equity Services LLC	5,422	$1.11M	0.0%	+29.7%	0.003%
10/31/2026	Kestra Private Wealth Services LLC	1,509	$0.31M	0.0%	N/A	0.001%
10/31/2026	Chicago Partners Investment Group LLC	2,941	$0.55M	0.0%	N/A	0.001%
10/31/2026	Covestor Ltd	619	$0.13M	0.1%	-33.9%	0.000%
10/30/2026	Rakuten Investment Management Inc.	11,058	$2.26M	0.0%	N/A	0.005%
10/30/2026	Provenance Wealth Advisors LLC	213	$44K	0.0%	N/A	0.000%
10/30/2026	Factory Mutual Insurance Co.	1,862	$0.38M	0.0%	N/A	0.001%
10/29/2026	Sumitomo Mitsui Trust Group Inc.	378,702	$77.73M	0.0%	+23.6%	0.177%
10/29/2026	Mirae Asset Global Investments Co. Ltd.	12,709	$2.61M	0.0%	N/A	0.006%
10/29/2026	Profund Advisors LLC	10,422	$2.14M	0.1%	+11.9%	0.005%
10/29/2026	ProShare Advisors LLC	7,432	$1.53M	0.0%	+6.6%	0.003%
10/29/2026	Vise Technologies Inc.	2,383	$0.49M	0.0%	-8.1%	0.001%
10/29/2026	Americana Partners LLC	6,339	$1.30M	0.0%	+22.5%	0.003%
10/29/2026	State of Wyoming	7,494	$1.54M	0.1%	-20.7%	0.003%
10/28/2026	CFC Planning Co LLC	8,700	$1.79M	1.0%	-5.6%	0.004%
10/28/2026	Raleigh Capital Management Inc.	734	$0.15M	0.0%	N/A	0.000%
10/28/2026	Parcion Private Wealth LLC	1,419	$0.29M	0.0%	N/A	0.001%
10/28/2026	Soltis Investment Advisors LLC	1,112	$0.23M	0.0%	N/A	0.001%
10/28/2026	Choreo LLC	4,049	$0.83M	0.0%	+201.9%	0.002%
10/28/2026	China Universal Asset Management Co. Ltd.	39,108	$8M	0.4%	+15.6%	0.000%
10/28/2026	North Dakota State Investment Board	16,547	$3.40M	0.1%	+210.2%	0.000%
10/27/2026	Asset Management One Co. Ltd.	66,600	$13.67M	0.0%	+7.0%	0.031%
10/26/2026	Oppenheimer & Co. Inc.	12,798	$2.63M	0.0%	-16.9%	0.006%
10/26/2026	Park Avenue Securities LLC	1,426	$0.29M	0.0%	N/A	0.001%
10/23/2026	Signaturefd LLC	2,157	$0.44M	0.0%	+32.7%	0.001%
10/23/2026	Citizens Financial Group Inc. RI	5,657	$1.16M	0.0%	-92.4%	0.003%
10/23/2026	Sterling Capital Management LLC	3,369	$0.69M	0.0%	-40.7%	0.002%
10/23/2026	Washington Trust Advisors Inc.	655	$0.13M	0.0%	+35.9%	0.000%
10/23/2026	Inspire Investing LLC	10,866	$2.23M	0.1%	+26.1%	0.005%
10/22/2026	Yousif Capital Management LLC	2,628	$0.54M	0.0%	+8.2%	0.001%
10/22/2026	MBL Wealth LLC	1,734	$0.36M	0.0%	N/A	0.001%
10/22/2026	Root Financial Partners LLC	628	$0.13M	0.0%	N/A	0.000%
10/22/2026	SBI Securities Co. Ltd.	1,710	$0.35M	0.0%	+12.9%	0.001%
10/21/2026	Crossmark Global Holdings Inc.	1,839	$0.38M	0.0%	+17.7%	0.001%
10/21/2026	Guardian Partners Inc.	7,500	$1.54M	0.1%	+66.7%	0.003%
10/21/2026	Englebert Financial Advisers LLC	4,441	$0.91M	0.9%	N/A	0.002%
10/21/2026	QP Wealth Management LLC	5,851	$1.20M	1.8%	N/A	0.003%
10/21/2026	Pinnacle Associates Ltd.	1,821	$0.37M	0.0%	N/A	0.001%
10/21/2026	Nisa Investment Advisors LLC	3,564	$0.73M	0.0%	-29.6%	0.002%
10/21/2026	Robeco Institutional Asset Management B.V.	22,319	$4.58M	0.0%	+439.1%	0.010%
10/20/2026	West Branch Capital LLC	500	$0.10M	0.0%	N/A	0.000%
10/20/2026	Bluestem Financial Advisors LLC	1,256	$0.26M	0.1%	+4.8%	0.001%
10/17/2026	SteelPeak Wealth LLC	7,403	$1.52M	0.0%	N/A	0.003%
10/17/2026	IFP Advisors Inc	810	$0.17M	0.0%	+8.7%	0.000%
10/16/2026	Vontobel Holding Ltd.	3,946	$0.81M	0.0%	N/A	0.002%
10/16/2026	TD Waterhouse Canada Inc.	370	$76K	0.0%	+37.0%	0.000%
10/15/2026	Assenagon Asset Management S.A.	2,181,185	$447.71M	0.3%	+987.9%	1.018%
10/15/2026	Curated Wealth Partners LLC	1,329	$0.27M	0.0%	N/A	0.001%
10/15/2026	Loftus Peak Pty Ltd	94,803	$19.46M	2.2%	-1.3%	0.044%
10/15/2026	Mather Group LLC.	202	$41K	0.0%	N/A	0.000%
10/15/2026	Hudock Inc.	986	$0.20M	0.0%	-32.9%	0.000%
10/14/2026	First Citizens Bank & Trust Co.	3,373	$0.69M	0.0%	N/A	0.002%
10/14/2026	Krilogy Financial LLC	1,751	$0.34M	0.0%	+38.6%	0.001%
10/13/2026	NorthCrest Asset Manangement LLC	1,949	$0.37M	0.0%	+42.3%	0.001%
10/13/2026	Avior Wealth Management LLC	1,725	$0.35M	0.0%	N/A	0.001%
10/10/2026	Armstrong Advisory Group Inc.	330	$68K	0.0%	+534.6%	0.000%
10/9/2026	Wedmont Private Capital	40,937	$7.70M	0.2%	+1.6%	0.019%
10/9/2026	Paragon Capital Management Ltd	1,273	$0.26M	0.0%	+13.3%	0.001%
10/9/2026	Chapin Davis Inc.	1,200	$0.25M	0.0%	N/A	0.001%
10/9/2026	GAMMA Investing LLC	2,266	$0.47M	0.0%	+7.9%	0.001%
10/8/2026	Farther Finance Advisors LLC	4,848	$1M	0.0%	+131.2%	0.002%
10/8/2026	CoreCap Advisors LLC	457	$94K	0.0%	+22,750.0%	0.000%
10/8/2026	Valeo Financial Advisors LLC	1,284	$0.26M	0.0%	+16.6%	0.001%
10/7/2026	Cooper Financial Group	1,800	$0.37M	0.0%	N/A	0.001%
10/1/2026	Burkett Financial Services LLC	133	$27K	0.0%	N/A	0.000%
9/23/2026	QRG Capital Management Inc.	8,083	$1.51M	0.0%	+31.6%	0.004%
9/22/2026	Andra AP fonden	28,200	$5.28M	0.1%	+69.9%	0.013%
9/10/2026	ABS Direct Equity Fund LLC	187	$35K	0.0%	-89.6%	0.000%
9/9/2026	Sequoia Financial Advisors LLC	3,342	$0.63M	0.0%	N/A	0.002%
9/9/2026	Tidal Investments LLC	109,096	$20.43M	0.0%	-20.5%	0.051%
9/9/2026	MCF Advisors LLC	415	$78K	0.0%	N/A	0.000%
9/9/2026	National Pension Service	273,604	$51.24M	0.0%	N/A	0.128%
9/9/2026	Engineers Gate Manager LP	7,380	$1.38M	0.0%	+144.0%	0.003%
9/9/2026	Integrated Wealth Concepts LLC	1,485	$0.28M	0.0%	N/A	0.001%
9/9/2026	NewEdge Advisors LLC	2,806	$0.53M	0.0%	N/A	0.001%
9/9/2026	IFP Advisors Inc	745	$0.14M	0.0%	+577.3%	0.000%
9/8/2026	Hudock Inc.	1,470	$0.28M	0.0%	N/A	0.001%
9/8/2026	Allworth Financial LP	2,240	$0.42M	0.0%	+227.5%	0.001%
9/8/2026	Arizona State Retirement System	46,382	$8.69M	0.0%	+17.7%	0.022%
9/8/2026	Waverly Advisors LLC	1,484	$0.28M	0.0%	N/A	0.001%
9/8/2026	Paragon Capital Management Ltd	1,124	$0.21M	0.0%	N/A	0.001%
9/8/2026	Nykredit A S	44,928	$8.41M	0.0%	N/A	0.021%
8/27/2026	Corient Private Wealth LP	10,537	$1.97M	0.0%	+5.9%	0.005%
8/26/2026	HighTower Advisors LLC	10,485	$1.96M	0.0%	+311.2%	0.005%
8/23/2026	Washington Trust Advisors Inc.	482	$90K	0.0%	N/A	0.000%
8/23/2026	Readystate Asset Management LP	37,727	$7.07M	0.2%	+18.5%	0.018%
8/23/2026	Ameritas Advisory Services LLC	256	$48K	0.0%	N/A	0.000%
8/23/2026	Wedmont Private Capital	40,281	$7.53M	0.2%	+0.1%	0.019%
8/23/2026	HB Wealth Management LLC	5,336	$1M	0.0%	+71.6%	0.002%
8/23/2026	Saudi Central Bank	11,324	$2.12M	0.0%	+111.6%	0.005%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $199.09

$192.34

$201.57

50 Day Range

MA: $198.45

$177.96

$221.15

52 Week Range

Now: $199.09

$58.00

$224.31

Volume

1,012,011 shs

Average Volume

2,776,577 shs

Market Capitalization

$42.67 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Rock Ventures Iii LP Third (Major Shareholder)
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Xiaolin Wang (Insider)
Lin Wei (Insider)
Margaret A Horn (Insider)
Lorence H Kim (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Assenagon Asset Management S.A. — 1.02%
Pictet Asset Management Holding SA — 0.47%
Candriam S.C.A. — 0.21%
Sumitomo Mitsui Trust Group Inc. — 0.18%
Loftus Peak Pty Ltd — 0.04%
Asset Management One Co. Ltd. — 0.03%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Candriam S.C.A.
Citizens Financial Group Inc. RI
Pictet Asset Management Holding SA
Oppenheimer & Co. Inc.
Sterling Capital Management LLC
State of Wyoming
Nisa Investment Advisors LLC
Loftus Peak Pty Ltd
In the last year, company insiders that have sold Revolution Medicines company stock include:
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Xiaolin Wang (Insider)
Lin Wei (Insider)
Alan B Sandler (Insider)
Sushil Patel (Director)
Lorence H Kim (Director)
Elizabeth M Anderson (Director)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
Assenagon Asset Management S.A.
Sumitomo Mitsui Trust Group Inc.
Robeco Institutional Asset Management B.V.
Mirae Asset Global Investments Co. Ltd.
North Dakota State Investment Board
Rakuten Investment Management Inc.
CenterBook Partners LP
SteelPeak Wealth LLC